Koninklijke Philips N.V. (NYSE:PHG) is one of the On May 6, 2026, Koninklijke Philips N.V. (NYSE:PHG) reported Q1 adjusted EPS of EUR 0.23 compared to EUR 0.25 last year.
Revenue totaled EUR 3.91B compared to EUR 4.1B in the prior-year period
The company said it delivered a solid start to 2026, with order intake growth of 6%, comparable sales growth of 4%, and adjusted EBITDA margin expansion of 40 basis points, supported by disciplined execution despite an uncertain macroeconomic backdrop. Philips added that sales growth was driven by North America and Europe and spanned all operating segments. The company also said it is advancing a new strategy focused on accelerating profitable growth through segment-specific priorities, platform-based innovation, and operational discipline.
Philips highlighted several AI-related developments during the quarter, including regulatory approval for SmartHeart, which automates cardiac MRI planning, and DeviceGuide, which adds AI-powered real-time guidance to cardiac procedures on the Azurion platform. Philips also pointed to continued demand for its OneBlade grooming platform. Koninklijke Philips N.V. (NYSE:PHG) maintained its FY26 outlook for comparable sales growth of 3%-4.5%, adjusted EBITDA margin of 12.5%-13%, and free cash flow of EUR 1.3 B-EUR 1.5 B.